DA-0016(Dongda Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDA-0016(Dongda Biotechnology)
Drug Alias NameDA-0016
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A